SBI LIFE INSURANCE COMPANY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,430 INR | -0.32% |
|
+0.32% | -0.21% |
| May. 17 | Indian Equities Extend Gains on Friday, Led by Real Estate, Auto and Metal Names | MT |
| May. 15 | INDICES - India & Brazil weaken |  |
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Sales forecast by analysts have been recently revised upwards.
Weaknesses
- The company has insufficient levels of profitability.
- With an expected P/E ratio at 74.24 and 67.22 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -0.21% | 17.31B | C+ | ||
| +12.66% | 110B | B | ||
| +21.74% | 108B | B- | ||
| -7.94% | 93.53B | B+ | ||
| +22.97% | 73.99B | D+ | ||
| +24.89% | 36.08B | B | ||
| +15.48% | 30.16B | B | ||
| +12.50% | 29.77B | A | ||
| -12.54% | 14.7B | B | ||
| +27.80% | 13.6B | A- |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
-
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SBILIFE Stock
- Ratings SBI Life Insurance Company Limited
